Table 3.
Functional deficits in antigen presentation in tumor cells of classical Hodgkin lymphoma, diffuse large B-cell lymphoma and primary central nervous system lymphoma patients.
| Antigen presentation capability | cHL % | NLPHL % | DLBCL % | PCNSL % | Testis % |
|---|---|---|---|---|---|
| “Normal” | 12.4 | 90.4 | 37.6 | 23.5 | 13.3 |
| HLA class I dysfunction | 17.6 | 4.8 | 19.7 | 17.7 | 0 |
| HLA class II dysfunction | 24.1 | 0 | 7.7 | 5.9 | 6.7 |
| HLA class I and II dysfunction | 45.9 | 4.8 | 35.0 | 52.9 | 80 |
Notes: Membraneous expression of HLA class I and class II with cytoplasmic HLA-DM. HLA class I dysfunction indicates loss of membraneous HLA class I staining with preserved membraneous HLA class II and cytoplasmic HLA-DM. HLA class II dysfunction refers to loss of HLA class II or loss of HLA-DM with preserved membraneous HLA class I. HLA class I and II dysfunction indicates loss of membraneous HLA class I combined with either loss of membraneous class II or loss of HLA-DM